Sanofi and GSK take COVID-19 vaccine into Phase 3 study May 27, 2021 Auto Bot Preclinical Research 0 Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.
